Estrogen receptor (ER) and progesterone receptor (PgR), by ligand-binding assay compared with ER, PgR and pS2, by immuno-histochemistry in predicting response to tamoxifen in metastatic breast cancer: a Southwest Oncology Group Study (Q73645071)
Jump to navigation
Jump to search
scientific article published on 01 March 2000
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Estrogen receptor (ER) and progesterone receptor (PgR), by ligand-binding assay compared with ER, PgR and pS2, by immuno-histochemistry in predicting response to tamoxifen in metastatic breast cancer: a Southwest Oncology Group Study |
scientific article published on 01 March 2000 |
Statements
Estrogen receptor (ER) and progesterone receptor (PgR), by ligand-binding assay compared with ER, PgR and pS2, by immuno-histochemistry in predicting response to tamoxifen in metastatic breast cancer: a Southwest Oncology Group Study (English)
R M Elledge
S Green
R Pugh
D C Allred
G M Clark
J Hill
P Ravdin
S Martino